Laboratory News and Research

RSS

LLNL leads multi-institutional collaboration in modeling protein interactions linked to cancer

Computational scientists, biophysicists and statisticians from Lawrence Livermore National Laboratory and Los Alamos National Laboratory are leading a massive multi-institutional collaboration that has developed a machine learning-based simulation for next-generation supercomputers capable of modeling protein interactions and mutations that play a role in many forms of cancers.

31 Oct 2019

$UTSA scientists study osteoporotic bone fractures to rethink treatment$

UTSA scientists study osteoporotic bone fractures to rethink treatment

About half of all women in the U.S. will suffer a bone fracture due to osteoporosis. For women, the incidence of this condition is greater than that of heart attack, stroke and breast cancer combined.

31 Oct 2019

New study sheds light on artificial networks and human face recognition

Our brains are so primed to recognize faces - or to tell people apart - that we rarely even stop to think about it, but what happens in the brain when it engages in such recognition is still far from understood. In a new study reported today in Nature Communications, researchers at the Weizmann Institute of Science have shed new light on this issue.

30 Oct 2019

MGH researchers create highest resolution MRI scan of the human brain

A new paper describes a breakthrough 100 micron resolution scan of the human brain that was created by a multidisciplinary team of Massachusetts General Hospital researchers.

30 Oct 2019

Rilpivirine drug used for HIV treatment also suppresses Zika virus infection

Like an adjustable wrench that becomes the "go-to" tool because it is effective and can be used for a variety of purposes, an existing drug that can be adapted to halt the replication of different viruses would greatly expedite the treatment of different infectious diseases.

30 Oct 2019

Researchers develop new leucocyte markers

An article entitled "Human Peripheral Blood Eosinophils Express High Levels of the Purinergic Receptor P2X4" written by an international immunology research group was recently published in the scientific journal Frontiers in Immunology.

30 Oct 2019

Syringe-injectable, self-expandable and ultraconformable magnetic nanosheets developed

Syringe-injectable biomaterials, medical devices and engineered tissues have attracted great attention as minimally-invasive implants for diagnosis, therapy and regenerative medicine.

30 Oct 2019

Liquid biopsy can predict prognosis in patients with glioblastoma

A blood test that measures the amount of cell-free DNA (cfDNA) in the bloodstream - called a liquid biopsy - correlates with how patients will progress after they are diagnosed with glioblastoma (GBM), the deadliest and most common primary brain tumor in adults.

30 Oct 2019

Wearable accelerometers are reliable predictors of mortality risk in older adults

A federally funded study by Johns Hopkins Medicine researchers shows that wearable accelerometers - mechanical sensors worn like a watch, belt or bracelet to track movement - are a more reliable measure of physical activity and better than patient surveys and other methods used by physicians at assessing five-year risk of death in older adults.

30 Oct 2019

Beckman Coulter receives BARDA funding to develop novel sepsis detection algorithm

Beckman Coulter, Inc., a Danaher company, today announced that it has initially been awarded a contract of $1.25 million, with potential to be awarded an additional $6.5 million if all contract options are exercised, from the DRIVe (Division of Research, Innovation, and Ventures) established by the Biomedical Advanced Research and Development Authority, under the Office of the Assistant Secretary for Preparedness and Response, within the United States Department of Health and Human Services.

From Beckman Coulter Diagnostics 30 Oct 2019

Improved Cas9 enzyme reduces chance of off-target CRISPR mutations

Genomics experts have discovered that when guide RNAs (gRNA) are designed properly, the risk of off-target mutations induced by the cas9 enzyme is very rare.

30 Oct 2019

New BD MAX Check-Points CPO assay receives FDA 510(k) clearance

BD (Becton, Dickinson and Company), a leading global medical technology company, along with Check-Points Health B.V., announced today that FDA 510(k) clearance was obtained for a molecular screening test for antibiotic-resistant carbapenemase-producing organisms on the fully-automated BD MAX System.

From BD (Becton, Dickinson and Company) 30 Oct 2019

Novel, cost-effective method successfully identifies aggressive tumors

Researchers have developed a novel, cost-effective genomic method that can identify highly heterogenous tumors that are typically aggressive in nature.

30 Oct 2019

TDP-43 study could speed up the diagnosis and treatment of ALS

A new study suggests that TDP-43 may be used as a biomarker in the diagnosis and treatment of amyotrophic lateral sclerosis (ALS).

30 Oct 2019

New method helps assess the health of human hair follicles

A variety of factors can stop hair from forming and growing properly, leading to hair diseases and baldness.

30 Oct 2019

IU researcher receives NIH grant to perform clinical trial on cirrhosis

An Indiana University School of Medicine researcher has been awarded a five-year, $1.8 million grant from the National Institutes of Health for a clinical trial, aimed at providing new avenues to improve liver function for patients with alcoholic cirrhosis.

30 Oct 2019

Researchers are confronting opioid epidemic in multiple ways

With opioid drug overdose deaths skyrocketing in recent decades, researchers at Brown University's School of Public Health are confronting the epidemic in multiple ways.

30 Oct 2019

Rock icon receives replacement heart valve in New York City hospital

Mick Jagger owes some thanks for the fact he's alive and strutting to Ajit Yoganathan and his lab crew. In fact, millions of people do.

30 Oct 2019

Rutgers selected to speed up development of biomedical health technologies

Rutgers, The State University of New Jersey was selected as one of five new hubs under the National Institutes of Health's Research Evaluation and Commercialization Hubs program to speed up the translation of biomedical discoveries into commercially viable diagnostics, devices, therapeutics, and tools to improve patient care, enhance health, and train the next generation of innovators.

29 Oct 2019